Cyntegrity’s & SynapCon’s Webinar RbM Practical Insights (Video)

Webinar description:

What risks does RbM intro­duce by itself? Why mon­i­tor­ing team does not accept the new RbM pro­ce­dure? How should sites be involved in RbM process?
Now, we can tackle these questions.

We are going to review the def­i­n­i­tion of Risk-based Mon­i­tor­ing (RbM) in clin­i­cal research. Dif­fer­ence of def­i­n­i­tions between FDA and EMA?

Answer “What it’s in it for me?” ques­tion. — Share real-life exam­ples of the RbM appli­ca­tion.
Iden­tify the dif­fi­cul­ties & poten­tial pit­falls of RbM application.In our webi­nar, we will devote our atten­tion to prac­ti­cal insights of imple­men­ta­tion risk-based mon­i­tor­ing strat­egy and appli­ca­tion of inno­v­a­tive soft­ware projects in this domain — con­trolled risks are man­age­able risks.

By |2016-11-16T18:35:46+00:00March 31, 2015|Blog|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment

Upcoming Events

  1. DIA Europe 2019

    February 5 - February 7

Register Today!

Get Free Test Access